108 related articles for article (PubMed ID: 10716758)
1. An overexpression of fibroblast growth factor (FGF) and FGF receptor 4 in a severe clinical phenotype of facioscapulohumeral muscular dystrophy.
Saito A; Higuchi I; Nakagawa M; Saito M; Uchida Y; Inose M; Kasai T; Niiyama T; Fukunaga H; Arimura K; Osame M
Muscle Nerve; 2000 Apr; 23(4):490-7. PubMed ID: 10716758
[TBL] [Abstract][Full Text] [Related]
2. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
Srivastava NK; Yadav R; Mukherjee S; Sinha N
Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
[TBL] [Abstract][Full Text] [Related]
4. Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease.
Srivastava NK; Yadav R; Mukherjee S; Pal L; Sinha N
Magn Reson Imaging; 2017 May; 38():163-173. PubMed ID: 28069416
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity.
Banerji CRS; Henderson D; Tawil RN; Zammit PS
Hum Mol Genet; 2020 Sep; 29(16):2746-2760. PubMed ID: 32744322
[TBL] [Abstract][Full Text] [Related]
6. [Expression of connective tissue growth factor in progressive muscular dystrophy].
Sun GL; Yao F; Jiang HK; Li P; Kazuhiro H
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):753-7. PubMed ID: 16255854
[TBL] [Abstract][Full Text] [Related]
7. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
[TBL] [Abstract][Full Text] [Related]
8. The increased PDGF-A, PDGF-B and FGF-2 expression in recurrence of salivary gland pleomorphic adenoma.
Soares AB; Demasi AP; Tincani AJ; Martins AS; Altemani A; de Araújo VC
J Clin Pathol; 2012 Mar; 65(3):272-7. PubMed ID: 22174424
[TBL] [Abstract][Full Text] [Related]
9. RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy.
Macaione V; Aguennouz M; Rodolico C; Mazzeo A; Patti A; Cannistraci E; Colantone L; Di Giorgio RM; De Luca G; Vita G
Acta Neurol Scand; 2007 Feb; 115(2):115-21. PubMed ID: 17212615
[TBL] [Abstract][Full Text] [Related]
10. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.
Matsuzaka Y; Kishi S; Aoki Y; Komaki H; Oya Y; Takeda S; Hashido K
Environ Health Prev Med; 2014 Nov; 19(6):452-8. PubMed ID: 25150707
[TBL] [Abstract][Full Text] [Related]
11. FSHD-like patients without 4q35 deletion.
Yamanaka G; Goto K; Ishihara T; Oya Y; Miyajima T; Hoshika A; Nishino I; Hayashi YK
J Neurol Sci; 2004 Apr; 219(1-2):89-93. PubMed ID: 15050443
[TBL] [Abstract][Full Text] [Related]
12. Alteration of fibroblast growth factor and receptor expression after acute pancreatitis in humans.
Ebert M; Yokoyama M; Ishiwata T; Friess H; Büchler MW; Malfertheiner P; Korc M
Pancreas; 1999 Apr; 18(3):240-6. PubMed ID: 10206481
[TBL] [Abstract][Full Text] [Related]
13. Clinical and histopathological heterogeneity in patients with 4q35 facioscapulohumeral muscular dystrophy (FSHD).
Wood-Allum C; Brennan P; Hewitt M; Lowe J; Tyfield L; Wills A
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):188-91. PubMed ID: 15043716
[No Abstract] [Full Text] [Related]
14. Phenotype of combined Duchenne and facioscapulohumeral muscular dystrophy.
Korngut L; Siu VM; Venance SL; Levin S; Ray P; Lemmers RJ; Keith J; Campbell C
Neuromuscul Disord; 2008 Jul; 18(7):579-82. PubMed ID: 18586493
[TBL] [Abstract][Full Text] [Related]
15. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
[TBL] [Abstract][Full Text] [Related]
16. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
[TBL] [Abstract][Full Text] [Related]
17. Expression of receptors for basic fibroblast growth factor on human periodontal ligament cells.
Takayama S; Murakami S; Nozaki T; Ikezawa K; Miki Y; Asano T; Terashima A; Okada H
J Periodontal Res; 1998 Aug; 33(6):315-22. PubMed ID: 9777581
[TBL] [Abstract][Full Text] [Related]
18. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
[TBL] [Abstract][Full Text] [Related]
19. Early-onset facioscapulohumeral muscular dystrophy type 1 with some atypical features.
Dorobek M; van der Maarel SM; Lemmers RJ; Ryniewicz B; Kabzińska D; Frants RR; Gawel M; Walecki J; Hausmanowa-Petrusewicz I
J Child Neurol; 2015 Apr; 30(5):580-7. PubMed ID: 24717985
[TBL] [Abstract][Full Text] [Related]
20. FAT1 Gene Alteration in Facioscapulohumeral Muscular Dystrophy Type 1.
Park HJ; Lee W; Kim SH; Lee JH; Shin HY; Kim SM; Park KD; Lee JH; Choi YC
Yonsei Med J; 2018 Mar; 59(2):337-340. PubMed ID: 29436205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
